That doji above the upper bb, a couple days ago, seems to be a very good sell indicator. Would be good if it can stay above $10. but I wouldn't count on it unless something fundamentally changes. Lower bb is down around 9.35 (which is still higher than the analyst price target of 9 - note below - don't know if it's changed since then). My guess is sideways to lower.
Had to go look at what caused the sell off...
Last June, Neurocrine (nasdaq: NBIX - news - people ) said Pfizer (nyse: PFE - news - people ) terminated their partnership for indiplon
decision to lay off its 200-person sales force is a disappointment
Samimy maintained a price target of $9 on Neurocrine and said indiplon could receive FDA approval in 2008
http://www.forbes.com/2006/07/27/neurocrine-0727markets16.html?partner=yahootix
Had to go look at what caused the sell off...
Last June, Neurocrine (nasdaq: NBIX - news - people ) said Pfizer (nyse: PFE - news - people ) terminated their partnership for indiplon
decision to lay off its 200-person sales force is a disappointment
Samimy maintained a price target of $9 on Neurocrine and said indiplon could receive FDA approval in 2008
http://www.forbes.com/2006/07/27/neurocrine-0727markets16.html?partner=yahootix
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
